| Database ID | Symbol | Body Site | Sample Type | Sample Name | Microbe | Project ID | AS Type | Group | Chr | PSI Visulization | Splicing Variant | Details |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1416337 | DAZAP2 | Lung | Cell line | Calu-3 | Control/Healthy;COVID-19 | GSE151513 | A3SS | G0/G1 | 12 | - |
PV=0.972 FDR=1 FC=-0.015 |
|
| 1416338 | MAP11 | Lung | Cell line | Calu-3 | Control/Healthy;COVID-19 | GSE151513 | A3SS | G0/G1 | 7 | - |
PV=1 FDR=1 FC=0.026 |
|
| 1416339 | REX1BD | Lung | Cell line | Calu-3 | Control/Healthy;COVID-19 | GSE151513 | A3SS | G0/G1 | 19 | - |
PV=0.719 FDR=1 FC=-0.066 |
|
| 1416340 | REX1BD | Lung | Cell line | Calu-3 | Control/Healthy;COVID-19 | GSE151513 | A3SS | G0/G1 | 19 | - |
PV=0.912 FDR=1 FC=0.007 |
